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Summary
Sphingomyelin is the main sphingolipid in Trypano-
soma brucei, the causative agent of African sleeping
sickness. In vitro and in vivo characterization of the
T. brucei neutral sphingomyelinase demonstrates
that it is directly involved in sphingomyelin catabo-
lism. Gene knockout studies in the bloodstream
form of the parasite indicate that the neutral sphin-
gomyelinase is essential for growth and survival,
thus highlighting that the de novo biosynthesis of
ceramide is unable to compensate for the loss of
sphingomyelin catabolism. The phenotype of the
conditional knockout has given new insights into
the highly active endocytic and exocytic pathways in
the bloodstream form of T. brucei. Hence, the forma-
tion of ceramide in the endoplasmic reticulum
affects post-Golgi sorting and rate of deposition of
newly synthesized GPI-anchored variant surface gly-
coprotein on the cell surface. This directly influ-
ences the corresponding rate of endocytosis, via the
recycling endosomes, of pre-existing cell surface
variant surface glycoprotein. The trypanosomes use
this coupled endocytic and exocytic mechanism to
maintain the cell density of its crucial variant
surface glycoprotein protective coat. TbnSMase is
therefore genetically validated as a drug target
against African trypanosomes, and suggests
that interfering with the endocytic transport of
variant surface glycoprotein is a highly desirable
strategy for drug development against African
trypanosomasis.
Introduction
The medically important protozoan kinetoplastid Trypano-
soma brucei, which cause African sleeping sickness, has
a complex life cycle that alternates between an insect
vector and a mammalian host (Matthews, 2005). Despite
this the phospholipid content found in these life cycle
stages are remarkably similar (Patnaik et al., 1993; Rich-
mond et al., 2010). Phosphatidylcholine (PC) and sphin-
gomyelin (SM) are the two most abundant phospholipid
species in eukaryotic cells and accounts for over half of
the total phospholipids in T. brucei membranes (Patnaik
et al., 1993).
Sphingolipids, the most common of which is SM, are
essential structural components of eukaryotic mem-
branes, and function in diverse cellular processes (Cowart
et al., 2006; Lahiri and Futerman, 2007). They are abun-
dant in the outer leaflet of the plasma membrane of many
cells but are also found in lysosomal membranes and
endoplasmic reticulum (ER) and the Golgi, where they
play an important role in controlling membrane fluidity
(Koynova and Caffery, 1995; van Meer et al., 2008).
Eukaryotic SM synthase activity has been observed in
the plasma membrane, but is primarily localized in the
Golgi, where it transfers the choline–phosphate head-
group from PC to ceramide. Ceramide can be formed
either via the de novo biosynthesis, which commences by
the condensation of serine with palmitoyl-CoA, or via
hydrolysis (degradation) of complex sphingolipids nor-
mally by sphingomyelinases (SMases) (Futerman and
Riezman, 2005).
The diversity of sphingolipid synthesis is a developing
area for anti-fungals because yeast synthesize significant
amounts of inositol phosphorylceramide (IPC), by the
transfer of the inositol-1-phosphate headgroup of phos-
phatidylinositol (PI) to ceramide, which is in contrast to
mammals, which only synthesize SM (Dickson et al.,
2006). Similarly various sphingolipid species and their
biosynthesis in kinetoplastid parasites have also drawn
attention due to their potential as novel chemotherapeutic
targets (Suzuki et al., 2008). Trypanosoma cruzi and
Leishmania both synthesize significant amounts of IPC
(Kaneshiro et al., 1986; Bertello et al., 1995; Uhrig et al.,
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1996; Zhang et al., 2007) via orthologues of the yeast
AUR1 inositol phosphoceramide synthase (Denny et al.,
2006). The viability of a Leishmania major promastigote
null of the serine palmitoyltransferase, the first enzyme of
the sphingoid base pathway, suggests that Leishmania do
not require sphingolipids (Zhang et al., 2003). However, it
was subsequently discovered that they use a sphingosine
lyase to generate ethanolamine (Zhang et al., 2007).
Procyclic T. brucei contain both SM and IPC (Güther
et al., 2006; Fridberg et al., 2008), while bloodstream
stage parasites contain no IPC only synthesizing SM and
minor amounts of ethanolamine phosphorylceramide
(EPC) (Bagnat et al., 2000; Sutterwala et al., 2008).
Recently, it has been discovered that mammalian stumpy
form T. brucei upregulate a mitochondrial SM synthase
(SLS1, Tb09.211.1030) (Kabani et al., 2009), responsible
for making IPC (Mina et al., 2009), and this is paralleled
by formation of IPC as identified by electrospray mass
spectrometry (ES-MS) (Kabani et al., 2009).
Together, these observations clearly indicate that sph-
ingolipid synthesis in African trypanosomes is develop-
mentally regulated. RNAi silencing of the TbSLS locus
(four tandem genes) leads to growth arrest, suggesting
synthesis of some or all sphingolipids are essential in
trypanosomes (Sutterwala et al., 2008).
In yeast, the sorting of glycosylphosphatidylinositol
(GPI)-anchored proteins is influenced by sphingolipid-
and ergosterol-rich lipid rafts (Zanolari et al., 2000), and
thus yeast are dependent on de novo synthesis of cera-
mide (Sutterlin et al., 1997). This ceramide is synthesized
in the ER and is transferred to the Golgi, by a process that
is independent of ATP and vesicular trafficking (Funato
and Reizman, 2001). The resulting IPC synthesized in the
Golgi (Levine et al., 2000) is essential for stable mem-
brane association of GPI-anchored proteins and subse-
quently their correct sorting and trafficking to the plasma
membrane (Watanabe et al., 2002).
Sphingolipid/cholesterol-rich membrane lipid rafts of
polarized mammalian epithelial cells have also been impli-
cated to be associated with GPI anchors, which strongly
influences the sorting of proteins leaving the Golgi (see
reviews by Muniz and Reizman, 2000; Chatterjee and
Mayor, 2001).
The abundant GPI-anchored variant surface glycopro-
tein (VSG) also strongly influences trafficking within the
secretory and endocytic pathways in bloodstream-stage
African trypanosomes (Engstler et al., 2004; Schwartz
and Bangs, 2006). Inhibition of the initial step in the sph-
ingolipid biosynthesis, even though essential for viability,
surprisingly seems to have no detrimental effect on VSG
trafficking to the cell surface (Sutterwala et al., 2007),
despite reports of the presence of VSG in detergent-
resistant membranes (Nolan et al., 2000; Denny et al.,
2001). Thus, the extent to which lipid rafts might influence
GPI-dependent trafficking in trypanosomes is still unclear
(Denny and Smith, 2004).
Seminal work by the Bangs’ group has resulted in the
hypothesis that post-Golgi sorting of soluble and GPI-
anchored cargo is influenced by the endocytic rate in each
particular life cycle stage of T. brucei (Tazeh et al., 2009).
This stage-specific variation is mirrored by the depen-
dency of clathrin in endocytosis in the bloodstream stage
(Allen et al., 2003), where the enlarged flagellar pocket,
known as the ‘Big-Eye’ phenotype is observed as mem-
brane vesicles continue to be delivered to the flagellar
pocket, but none are internalized via the endocytic
pathway from the flagellar pocket; the only site of endocy-
tosis and exocytosis in these parasites (reviewed in
Overath and Engstler, 2004).
Intracellular degradation of sphingolipids is achieved by
SMases [EC. 3.1.4.12], which catalyses their hydrolysis to
form ceramide and the corresponding headgroup i.e.
phosphorylcholine in the case of SM.
Various SMases have been described, which differ in
their subcellular localization, tissue specificity and are
normally activated by growth factors, cytokines, chemo-
therapeutic agents, irradiation, nutrient removal and other
related stresses (Tomiuk et al., 1998; Yabu et al., 2008).
Some or all of these are thought to regulate the intracel-
lular ceramide concentration and the corresponding
stress-induced associated responses.
To date, there are five main types of SMases; the acidic
Zn2+-dependent (cytosolic/secreted) and independent
(lysosomal), the neutral Mg2+-dependent (membrane) and
independent (cytosolic) and lastly the secreted alkaline
SMase (reviewed in Goni and Alonso, 2002).
There is a growing body of evidence that suggests
Mg2+-dependent neutral SMases (nSMases) are the major
source for stress-induced ceramide production (Yabu
et al., 2008). Ceramide and associated metabolites, such
as sphingosine-1-phosphate, are known to function as
second messengers, causing various biological activities
in mammalian cells, including activation of protein-
kinases and/or protein-phosphatases 2A (Huwiler et al.,
2000). Increased levels of ceramides can exert anti-
proliferation effects, induce apotosis and play major roles
in mitogenesis and endocytosis.
Neutral SMases were first cloned from Bacillus cereus
(Yamada et al., 1988), which allowed identification
of nSMases in other bacteria including Listeria
ivanovii (Gonzalez-Zorn et al., 1999). Through homology
searches the yeast homologues (Sawai et al., 1999) and
subsequently the mammalian homologues were identified
(Tomiuk et al., 1998; Hofmann et al., 2000). Despite the
extensive literature on nSMase activity it is only compara-
tively recently that mammalian nSMases have been
cloned and characterized. Neutral SMases are ubiqui-
tously expressed in mammalian cells, where they are
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predominately membrane-bound on the outer leaflet of
the plasma membrane (Tomiuk et al., 1998), where most
of the SM is located.
Plasmodium also contains a bacterial nSMase homo-
logue, which is capable of cleaving both SM and lyso-PC
(Hanada et al., 2002). Intriguingly, the compound scy-
phostatin inhibits this plasmodium enzyme activity, as well
as preventing maturation from trophozoite to schizont at
low mM concentrations (Hanada et al., 2000).
The yeast nSMase homologue Isc1 has been shown to
be associated with the ER, during early growth, while in
late logarithmic growth it is found in the outer leaflet of the
mitochondria where it seems to regulate sphingolipid
metabolism (Vaena de Avalos et al., 1998; Kitagaki et al.,
2007). The Isc1 protein has inositol sphingolipid phospho-
lipase C activity, i.e. capable of cleaving IPC to generate
ceramide, which seems to be required for normal mito-
chondrial function (Sawai et al., 2000). Further recent
studies have elaborated on this, by clearly showing that
the knockout of Isc1 is essential during a diauxic shift, i.e.
it plays a crucial role in the reprogramming of mitochon-
drial gene expression during the transition from anaerobic
to aerobic metabolism, coupled with a change in carbon
source (Kitagaki et al., 2009).
In this study, we begin to investigate the catabolism of
sphingolipids in T. brucei.
Here we show the recombinant expression and charac-
terization of the only T. brucei nSMase. We also report on
the creation of a T. brucei conditional null mutant, which
demonstrates that the nSMase activity is essential for the
bloodstream form of the parasite, causing VSG trafficking
to be impaired.
Results
Cloning and sequencing T. brucei nSMase
An nSMase homologue was putatively identified in the T.
b. brucei (strain 927) genome database (Sanger Insti-
tute) by interrogating with the Saccharomyces cerevisiae
nSMase (Isc1). This open reading frame (ORF)
(Tb927.5.3710) was PCR-amplified from T. b. brucei
strain 427, subcloned and sequenced. The sequence
has been submitted to EMBL-EBI, Accession No.
FM992873. An alignment of the predicted translated
sequence with nSMases from other organisms is shown
in Fig. S1A and an unrooted phylogenetic tree in
Fig. S1B. The predicted 65 kDa T. brucei nSMase
(TbnSMase) has two putative transmembrane domains
(Fig. S1A, underlined) towards the C-terminus, which are
present in most eukaryotic nSMases, and contains the
conserved residues critical for catalytic activity and Mg2+
binding (Fig. S1A, asterisks). Although TbnSMase shows
considerable similarity to nSMases from a variety of
organisms, there are significant regions of the sequence,
which are different between the kinetoplastid nSMase
homologues (identified here) and the other nSMases
including the human protein. Outside of the kinetoplasts
the closest homologue is surprisingly the honey-bee
(Apis mellifera).
Overexpression of TbnSMase in E. coli
To enable biochemical characterization, TbnSMase was
recombinantly expressed in E. coli using a pGEX-6P-1
vector. The N-terminal GST fusion protein (full-length,
membrane bound) was expressed in E. coli C43 (DE3)
cells, a bacterial host that allows the synthesis of poten-
tially toxic membrane proteins (Miroux and Walker,
1996). The apparent molecular weight of this GST–
TbnSMase fusion protein was ~81 kDa by Western blot
analysis (Fig. 1A, lane 2), smaller than the predicted
size of 91 kDa (including the GST tag). A significant pro-
portion of the protein as expected was found in the
membrane fraction (Fig. 1A, lane 3). These membranes
were washed in phosphate-buffered saline (PBS) and
suspended in 100 mM Tris (pH 7.4), 10 mM MgCl2 buffer
containing 20% glycerol, and aliquots were stored at
-80°C without loss of activity. Total protein content was
calculated to be 50.8 mg ml-1 of this membrane prepara-
tion. Enzyme activity was assessed by incubation of
GST–TbnSMase containing membranes (127 mg protein)
with either 25 nCi/50.5 pmol of [3H-choline-methyl] SM or
30 nCi/50.5 pmol of [3H-choline-methyl] PC, as mixed
micelles with 0.1% Triton-X 100. Reactions were incu-
bated at 37°C for 120 min in 100 mM Bis-Tris propane
(pH 7.5), 5 mM MgCl2, 1% glycerol in the presence or
absence of 5 mM EDTA. Chloroform/methanol/water
phase separation was used to distinguish the radiola-
belled lipid substrates from any aqueous radiolabelled
products, which were subjected to scintillation counting
and thin-layer chromatography. The assay showed that
the membranes containing GST–TbnSMase was cata-
lytically active (Fig. 1B, compare lanes 1 and 2) and was
also divalent cation-dependent (Fig. 1B, compare lanes
2 and 3). No activity towards PC was apparent (Fig. 1B,
lanes 6–8), while no SMase activity was observed
in equivalent E. coli membranes not containing
GST–TbnSMase (Fig. 1B, lanes 4 and 5). The optimum
pH of the GST–TbnSMase activity is pH 8, with very
little activity at pH 5.5 (Fig. 1C), representative of an
nSMase.
Sphingomyelinase activity was similarly detected
through the use of a multi-well plate, fluorescence-
based, coupled assay (Invitrogen), whereby the product
of SMase activity, choline–phosphate, is hydrolysed by
alkaline phosphatase, and the released choline is oxi-
dized to betaine and H2O2 (Fig. 2A). Production of H2O2
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in the presence of horseradish peroxidase drives the
conversion of the Amplex Red reagent to the red-
fluorescent resorufin, detectable using a fluorescence
microplate reader (Molecular Devices Gemini XPS). The
TbnSMase activity showed saturation kinetics were
observed, with an apparent Km of 45.7  6.5 mM and
Vmax of 424.0  32.6 nmol h-1 mg-1 membrane protein
(Fig. 2B).
Other homologous divalent cation-dependent nSMases
assayed in a similar manner have similar kinetic proper-
ties including the following: (i) S. cerevisiae ISC1 (over-
expressed in S. cerevisiae JK9-3da cell lysates) with a Km
of 34.8 mM and a Vmax of 9200 nmol h-1 mg-1 (Sawai et al.,
2000); and (ii) Plasmodium falciparum nSMase (GST
fusion expressed in E. coli membranes) with an apparent
Km of ~90 mM and a specific activity of 5.69 
0.29 nmol h-1 mg-1 (Hanada et al., 2002). Three mamma-
lian homologues have also been kinetically characterized:
(i) rat nSMase (GST fusion partially purified from E. coli )
with an apparent Km of 3.85  0.73 mM and a Vmax of
239.1  33.2 nmol h-1 mg-1 (Mizutani et al., 2000); (ii)
bovine nSMase (detergent extracted from bovine brain
membranes) with an apparent Km of ~40 mM and a spe-
cific activity of 371 nmol h-1 mg-1 (Bernardo et al., 2000);
and (iii) human nSMase1 (His-nSMase expressed
HEK293 cell lysates) with a Km of 26.2  10.5 mM and a
specific activity of 126.8  17.4 nmol h-1 mg-1) (Sawai
et al., 1999).
Sphingomyelinase activity, at a slightly reduced rate,
was also detected using equivalent amounts of E. coli
membranes expressing an N-terminal His-tagged
version of the TbnSMase protein (Fig. S2), while again
no activity was detected towards PC (Fig. S2, lane 3).
The fluorescence-based coupled assay is amenable to
high-throughput screening for inhibitors of the recombi-
nant TbnSMase. This allowed the determination of IC50
values of various compounds including known nSMase
inhibitors such as the dihydroimidazolo-amide GW4869
(Luberto et al., 2002) and Manumycin A (Fig. 2C) (Arenz
et al., 2001), which gave IC50 values of 14.4  2.3 mM
and 24.6  4.6 mM respectively. Manumycin A also has
an ED50 of 10.0  6.5 mM; however, it should be noted
Fig. 1. Expression, purification and activity
of recombinant TbnSMase.
A. TbnSMase was cloned and expressed
as an N-terminal GST fusion protein in C43
E. coli. Protein samples after cell disruption
were separated on a 10% SDS-PAGE gel,
transferred to membrane and detected with
anti-GST antibody. Lane 1, soluble protein
(supernatant from 100 000 g); lane 2,
membrane fraction (pellet from 100 000 g);
lane 3, insoluble fraction (pellet from
45 000 g).
B. The substrate [3H]-sphingomyelin (SM) and
the product [3H]-choline–phosphate of the
TbnSMase assay were separated by phase
partitioning (organic and aqueous
respectively), analysed by HPTLC and
detected by autoradiography as described in
Experimental procedures. Lane 1, negative
control, [3H]-SM with no membranes; lane 2,
[3H]-SM with TbnSMase; lane 3, [3H]-SM with
TbnSMase in presence of EDTA (5 mM); lane
4, negative control, [3H]-SM with non
expressing TbnSMase membranes; lane 5,
[3H]-SM with non-expressing TbnSMase
membranes and EDTA (5 mM).; lane 6,
[3H]-PC with no membranes; lane 7, [3H]-PC
with TbnSMase; lane 8, [3H]-PC with
TbnSMase in the presence of EDTA (5 mM).
Percentages of substrate turnover are shown,
as determined by densitometry (ImageJ
software).
C. TbnSMase activity was determined by
end-point radioactive assay as a function of
pH, using with MES buffer (filled triangles) or
Bis-Tris Propane (filled squares) as described
in Experimental procedures.
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that it has previously been shown to be trypanocidal,
with the suggestion of it being a farnesyl transferase
inhibitor (Ali et al., 1999), in light of our findings that it
may be that Manumycin A has multiple trypanocidal
targets. The lyso-PC analogues miltefosine and edelfos-
ine (structure insert Fig. 2D) are also inhibitors of the
nSMase activity in T. brucei membranes (Fig. 2D,
lanes 1–3) and recombinant GST–TbnSMase activity
(Fig. 2D, lanes 4–6). Edelfosine is more potent that
miltefosine, such that it has an IC50 of 21.0  3.2 mM
against the recombinant GST–TbnSMase (Fig. 2D,
lane 6).
Fig. 2. Activity of recombinant TbnSMase.
A. Reaction catalysed by TbnSMase along with coupled the coupled Amplex red assay. AP, alkaline phosphatase; ChOx, choline oxidase;
Cho-P, choline–phosphate; HRP, horseradish peroxidase.
B. Determination of TbnSMase Michaelis-Menten constants for SM (inserts show Lineweaver–Burk plot).
C. Structure of manumycin A, a commercially available nSMase inhibitor.
D. Enzyme activity of TbnSMase in either washed bloodstream T. brucei membranes (lanes 1–3) or E. coli membranes expressing
GST–TbnSMase (lanes 4–6), after pre-incubation with either nothing (lanes 1 and 4) or miltefosine (lanes 2 and 5) or edelfosine (lanes 3 and
6) in the presence of SM as substrate as described in Experimental procedures. Insert shows structure of edelfosine.
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nSMase is located in the endoplasmic reticulum in the
bloodstream form of T. brucei
The cellular location of TbnSMase was investigated using
the tetracycline-inducible overexpression vector pLew82,
containing a full-length TbnSMase with a C-terminal
HA-tag. This construct was introduced into bloodstream
form T. brucei cells, generating the cell line TbnSMase-
HA Ti and integration was confirmed by PCR using specific
vector primers (data not shown). Tetracycline-induced
TbnSMase-HA Ti cells were fixed, adhered to poly-lysine
slides and permeablized. The TbnSMase-HA Ti protein
was detected by immunofluorescence as a perinuclear
staining with some reticular cytoplasmic signal (Fig. 3A
and Fig. S3), suggesting that TbnSMase is localized in
the ER. This was confirmed by subcellular fractionation
studies, where the membrane bound TbnSMase-HA
protein was detected in the microsomal fraction and not
the cytosolic fraction (Fig. 3B).
TbnSMase is an essential gene in the bloodstream form
of T. brucei
Southern blot analysis of T. brucei genomic DNA
showed that TbnSMase is present as a single copy gene
per haploid genome (data not shown), and RT-PCR
analysis clearly shows that the TbnSMase is expressed
in both bloodstream and procyclic forms of the parasite
(Fig. S4), thus making it amenable to genetic validation
as a drug target. One allele of TbnSMase was replaced
with a knockout cassette containing the puromycin drug
resistance gene, by homologous recombination and
selection with puromycin, creating the DTbnSMase::PAC
cell line (Fig. 4A, Lane 1). Attempts to create a null
mutant by homologous replacement of the second allele
with the hygromycin resistance gene were unsuccessful.
Therefore, as the ‘wild-type’ cell line used here consti-
tutively expresses the T7 RNA polymerase and the tet-
racycline repressor protein, a tetracycline-inducible (Ti)
HA-tagged ectopic copy of the TbnSMase was inte-
grated in the rDNA locus (Wirtz et al., 1999) via a modi-
fied version of the pLew100 vector encoding the
blasticidin drug resistance protein (previously con-
structed in the Smith lab) forming the TbnSMase-HA Ti
DTbnSMase::PAC cell line (Fig. 4A, Lane 2). The second
allele was replaced with the hygromycin resistance
gene in the presence of tetracycline. A TbnSMase-
HA Ti DTbnSMase::PAC/DTbnSMase::HYG clone was
obtained and the genotype confirmed by Southern blot
analysis (Fig. 4A, Lane 3). To establish the essentiality
of TbnSMase in bloodstream T. brucei, the growth of the
TbnSMase-HA Ti DTbnSMase::PAC/ DTbnSMase::HYG
conditional knockout (cKO) cell line was monitored in the
absence and presence of tetracycline in certified
tetracycline-free HMI-9. In the presence of tetracycline
the cKO cell line showed normal growth rates when
compared with wild-type cells (Fig. 4B). However, in the
absence of tetracycline, the cells grew normally for ~24–
28 h before ceasing division and steadily declined in cell
numbers to below the limits of detection by light micros-
copy by day 5. At day 10 however, some live cells were
visualized having wild-type morphologies that subse-
quently resumed normal growth kinetics. RT-PCR analy-
sis showed that the transcript level of the ectopic
TbnSMase-HA Ti was similar to that of the endogenous
copy seen for wild-type cells (Fig. 4C, compare lanes1
and 2). In the absence of tetracycline for 24 h the tran-
script of TbnSMase-HA Ti was undetectable (Fig. 4C,
lane 3), whereas in the revertant cells, a transcript for
the TbnSMase-HA Ti is clearly shown (Fig. 4C, lane 4),
suggesting that these revertant cells overcome the tet-
racycline control, a phenomena that has been described
for other essential genes in T. brucei (Chang et al.,
2002; Roper et al., 2002; Martin and Smith, 2006a).
Fig. 3. Localization of TbnSMase-HA Ti in bloodstream form
T. brucei.
A. Fixed TbnSMase-HA Ti cells were incubated with rat anti-HA
antibody, and rabbit anti-rat FITC conjugated antibody and DNA
stained with DAPI.
B. Anti-HA Western analysis of fractions from differential
centrifugation, 14 500 g pellet (1), 140 000 g pellet (2) and
supernatant of 140 000 g pellet (3) of TbnSMase-HA Ti cells,
prepared as described in the Experimental procedures.
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Lipidomic analysis of the nSMase conditional knockout
The biochemical phenotype of the TbnSMase condi-
tional knockout cells was first investigated using mass
spectrometry to examine differences in phospholipid
species between the wild-type and nSMase conditional
knockout trypanosomes. Based on the growth curve
(Fig. 4B), 42 h without tetracycline was chosen as the
optimum time point to characterize the TbnSMase cKO
phenotype, as the cells were still viable and metaboli-
cally active. Six hours later (48h–tet) this is not the case,
thus 42 h was deemed the most extreme point at which
to investigate the advanced phenotype without studying
dying cells.
Initially, ES-MS was used to examine the phospholipid
content of whole-cell extracts from TbnSMase-depleted
cells, focussing initially on the positive ion mode for detec-
tion of both PC and SM. However, no differences in the
parent species of the collision-induced daughter ion char-
acteristic of PC and SM phospholipids (parents of
184 m/z) were observed between wild-type and cKO cells
cultured in the absence of tetracycline for 42 h (TbnS-
Mase cKO (42h–tet)) (Fig. S5). Also only very minor
changes were detected in the corresponding negative ion
survey scans (Fig. S6A). Parent ion and neutral loss
scanning of individual phospholipid classes were acquired
for PI, phosphatidylethanolamine (PE), phosphati-
dylserine (PS) (Fig. S6B–D). The only difference of any
note when compared with wild-type bloodstream form
phospholipid spectra was the unexpected presence
of inositolphosphorylceramide (IPC) (34:1, 778m/z)
(Fig. S6B, arrow).
Consequently, it was hypothesized that any potential
differences in the phospholipid profiles may be in a par-
ticular organelle such as the ER. Thus, lipids were
extracted from a microsomal fraction (100,000g pellet,
Fig. 4. TbnSMase is essential for the
survival of bloodstream form Trypanosoma
brucei in culture.
A. Confirmation of genotype of T. brucei
TbnSMase conditional double knockout cell
line. Southern blot analysis of Pst1-digested
genomic DNA (3 mg); the TbnSMase ORF
probe shows allelic TbnSmase at 4 kb and
the ectopic copy – TbnSMase-HATi at ~2 kb;
parental cells (lane 1);
DnSMase:::PAC/TbnSMase-HATi (lane 2);
DnSMase:::PAC
DnSMase:::HYG/TbnSMase-HATi (lane 3).
B. Growth curves of T. brucei parental cells (1
– filled squares) and TbnSmase conditional
knockout cells grown in the presence (2 –
empty circles) or absence (3 – filled triangles)
of tetracycline.
C. RT-PCR amplification of TbnSMase RNA
transcripts from total RNA extracted from
wild-type cells (lane 1) and TbnSMase
conditional null mutants either grown in the
presence (lane 2) or absence of tetracycline
for 1 and 10 days (lanes 3 and 4
respectively). The upper panel shows RT-PCR
products using primers specific for
TbnSMase; the lower panel shows a loading
control using (TbINO1) primers.
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P100), representing internal organelle membranes, from
both wild-type and TbnSMase cKO (42h–tet) trypano-
somes and analysed by ES-MS and ES-MS-MS. Upon
collision-induced daughter ion scanning for choline–
phosphate phospholipids (parents of 184 m/z), i.e. PC
and SM (Fig. 5A and B), differences were observed.
These included a significant decrease in the PC species
at 771 m/z (alkylacyl 36:2), as well as minor decreases in
PC species at 807 m/z (diacyl C38:5) and 835 m/z (diacyl
C40:5) (Fig. 5A and B, species highlighted with asterisks).
This decrease is in contrast with the significant increase in
the SM species at 703 m/z (C16:0) and minor increases in
the SM species at 677 m/z (C14:0) and 731 m/z (C18:0).
Fully characterization of the choline–phosphate contain-
ing phospholipids in T. brucei is shown in Table S1 (Rich-
mond et al., 2010).
In contrast, the negative ion survey scan of the P100
subcellular membrane fraction of wild-type cells (Fig. 5C)
only showed one major species at 771 m/z, identified by
ES-MS/MS daughter ion fragmentation (Fig. S7A) as
phosphatidylglycerol (PG) (diacyl, C36:3, a mixture of
C18:1, C18:2 and C18:0, C18:3). The corresponding
negative ion survey scan of the TbnSMase cKO (42h–
tet) P100 fraction (Fig. 5D), also showed the PG (diacyl,
C36:3) species to be the major species; however, there
was a significant increase in two species at 641 m/z and
669 m/z (Fig. 5D, marked with an asterick), identified by
ES-MS/MS daughter ion fragmentation (Fig. S7B), as
diacylglycerol (DAG) species C38:5 (C16:0, C22:5) and
C40:5 (C18:0, C22:5) respectively. As with the whole-cell
extracts, the presence of IPC (34:1, 778m/z) was
observed in the TbnSMase cKO (42h–tet) P100 fraction
of inositol-phosphate containing phospholipids (parents
of 241 m/z) (Fig. S7C). IPC is normally not present in
bloodstream form T. brucei, but is in procyclic and
stumpy form parasites (Güler et al., 2008; Kabani et al.,
2009).
Taken together, this set of data clearly shows an
increase of SM species at the organelle level due to the
lack of nSMase activity. The corresponding decrease in
Fig. 5. Mass spectrometric analyses of
phospholipids. Choline-containing
phospholipids extracted from the P100
fraction as described in Experimental
procedures were analysed by ESI-MS/MS in
positive ion mode using parent-ion scanning
of the collision induced fragment for
phosphorylcholine at 184 m/z in (A) parental
cells. (B) TbnSMase cKO cells grown in the
absence of tetracycline for 42 h. ESI-MS
negative ion survey scan spectra of P100 lipid
extracts from T. brucei bloodstream form cells.
(C) Parental cells. (D) TbnSMase cKO cells
grown in the absence of tetracycline for 42 h.
Asterisks highlight ions, which are altered
significantly in intensity, as described in the
text.
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PC is explainable by a lack of the choline–phosphate
product from SM hydrolysis by TbnSMase in the ER, thus
reducing the flux through the Kennedy pathway of de
novo PC biosynthesis. Alternatively, or most likely concur-
rently, SM is being synthesized at the expense of deplet-
ing the pool of PC by the SM synthases.
Loss of nSMase activity leads to a
‘Big-Eye’-like phenotype
The TbnSMase cKO cell line grown in the absence of
tetracycline exhibited a phase light structure at the poste-
rior end, which significantly increases in volume with time.
This enlarged structure eventually becomes the major
proportion of the cell volume and the trypanosomes
become rounded with time (Fig. 6B–D) compared with
wild-type cells (Fig. 6A). Concurrently, the proportion of
these abnormal cells increased through time such that at
42 h, ~25% of nSMase cKO cells exhibit this morphology,
increasing to over 50% of the cells at 72 h, compared with
<1% of wild-type cells. This morphology is similar to the
‘Big-Eye’ phenotype described previously with the RNA
interference (RNAi) of the clathrin heavy chain in T. brucei
bloodstream forms (Allen et al., 2003). Allen and col-
leagues used immunogold a-VSG electron microscopy to
confirm that the phase light structure was the flagellar
pocket, massively enlarged from the small flask-shaped
structure usually seen in wild-type cells.
Electron microscopy of the TbnSMase cKO grown
under permissive conditions also showed the highly
enlarged flagellar pocket (Fig. 6H–J), when compared
with the wild-type cells (Fig. 6E–F, further EM micro-
graphs in Fig. S8).
This ‘Big-Eye’ enlargement of the flagellar pocket can
be attributed to a defect in membrane transport whereby
the balance of exocytosis and endocytosis are disturbed.
The decrease in fluid endocytosis in TbnSMase cKO
(42h–tet) cells (Fig. 6L–N), compared with wild-type
cells (Fig. 6K), was confirmed with FITC-BSA uptake
by immunofluorescence. The FITC-BSA signal can be
observed frequently in the endosomal network and occa-
sionally at the flagellar pocket in wild-type cells (Fig. 6K),
but is significantly more frequently associated with just the
flagellar pocket in the TbnSMase cKO (42h–tet) cells; only
a fraction is endocytosed after 30 min (Fig. 6O, lanes
4–6), compared with a significant portion of the FITC-BSA
being endocytosed in the wild-type cells (Fig. 6O,
lanes1–3) (Fisher’s exact test, P = 0.056, n = 40 fields).
Extreme morphological ‘Big-Eye’ trypanosomes typically
demonstrated no specific FITC staining even with longer
camera exposures (Fig. 6H).
As with the clathrin RNAi ‘Big-Eye’ trypanosomes,
TbnSMase cKO (42h–tet) cells could be seen to be
undergoing mitosis and sometimes presented with two
phase-light structures (Fig. 6C, D and N), one larger
flagellar pocket confirmed to be the original, and a smaller
daughter flagellar pocket exocytically active prior to
cytokinesis (Allen et al., 2003). Associated with this ‘Big-
Eye’ phenotype was a noticeable increase in pre-
cytokinesis 2K2N cells. This lack of proper cell-division of
the TbnSMase cKO (-tet) was confirmed by FACS analy-
sis, which showed a significant increase in the proportion
of G2/M, with a corresponding decrease in G0/G1 cells
(Fig. 6P), implying a cell cycle arrest at G2/M.
To ensure that the enlargement of the flagellar pocket in
this cell line is similar to the previously described ‘Big-Eye’
defect in endocytosis phenotype, several previously well-
characterized proteins that are sorted by the endosomal
network were investigated.
Does the loss of nSMase affect protein trafficking?
As a diagnostic marker for membrane protein trafficking in
bloodstream form T. brucei, the processing of p67 in
TbnSMase cKO cells was examined. It is well docu-
mented that the terminal endosomal marker p67, a type I
membrane protein, undergoes complex processing in
bloodstream form trypanosomes (Brickman and Balber,
1994). From its synthesis as an ER-associated 100 kDa
glycoprotein (gp100), p67 is further N-glycosylated to a
150 kDa species (gp150) in the Golgi, before being trans-
ported and proteolytically cleavage in the lysosome,
forming firstly gp75 and subsequently gp28, gp32, gp42.
Using the method of Alexander et al. (2002), this process-
ing can be monitored. Thus, wild-type and TbnSMase
cKO (42h–tet) cells pulse labelled for 1 h with [35S]-
methionine were immunoprecipitation at 0 and 2 h post
pulse, using the monoclonal a-p67 (mAb280 – a gift of J.
Bangs). Analysis of the [35S]-methionine-labelled immuno-
precipitates by SDS-PAGE and autoradiography revealed
that proteolytic processing in the p67 through the gp75
intermediate to the end products gp32 and gp42 was
unaffected by the lack of TbnSMase (Fig. 8A, compare
lanes 1 and 2, with 3 and 4, loading controls Fig. S9).
Similarly, the trafficking of lumenal proteins in
TbnSMase cKO cells was investigated by examining the
processing of trypanopain, a cathepsin L orthologue. In
wild-type bloodstream form trypanosomes, trypanopain
is synthesized as a 53 kDa pro-protein and rapidly
fully processed in the acidic environment of the endoso-
mal network into a 44 kDa mature active enzyme
(Caffrey et al., 2001), similarly observed by ourselves
using Western blot analysis with a-trypanopain Ab
(a gift of J. Bangs) (Fig. 8B, lane 1). However, in TbnS-
Mase cKO (42h–tet) cells, proteolytic processing of
trypanopain is incomplete with 2–5% of the immature
53 kDa pro-enzyme detectable by Western blot (Fig. 8B,
lane 2).
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Fig. 6. Morphological phenotype of the
TbnSMase conditional knockout.
A–D. Merged DAPI-fluorescence-DIC images
of wild-type (A), and TbnSMase cKO cells
grown in the absence of tetracycline for 42 h
(B–D).
E–J. Transmission electron micrographs taken
of wild-type bloodstream T. brucei (E–G) and
TbnSMase cKO cells grown in the absence of
tetracycline for 42 h (H–J). Insert in (I) shows
a close up of the plasma membrane,
microtubles and the fussy VSG coat. FL,
flagellum; FP, flagellar pocket; K, kinetoplast;
M, mitochondria; G, glycosome; The asterisk
in (J) indicates that enlarged concentric
membrane structure may be part of the
endosomal network.
K–O. Wild-type (K) and TbnSMase cKO cells
grown in the absence of tetracycline for 42 h
(L–N) were incubated with FITC-BSA as
described in Experimental procedures; images
are merged FITC, DAPI-fluorescence and
DIC. (O) Evaluation of the endocytic function
of wild-type (1–3) and nSMase cKO (Tet-42h)
(4–6) trypanosomes were assessed for the
incidence of the FITC-BSA signal either solely
in the endosomal region (1 and 4), or dual
endosomal and flagellar pocket staining (2
and 5) or flagellar pocket staining only (3
and 6).
P. FACS analysis of TbnSMase cKO cells
grown in the absence of tetracycline for 0, 24
and 42 h. Cells were fixed, stained with
propidium iodide and analysed by flow
cytometry as described in Experimental
procedures.
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Examination in TbnSMase cKO cells (42h–tet) of the
subcellular localization of trypanopain, which typically
colocalizes with p67 in the lysosome (Caffrey et al., 2001),
shows that the endosomal staining pattern is greatly
enlarged (Fig. 7B–D and Fig. S10) compared with the
corresponding wild-type staining pattern (Fig. 7A). In
addition, extension of the endosomal staining is congru-
ent with the expansion of the late endosomal network and
flagellar pocket. This indicates that the endosomal
network is malfunctioning, probably as a result of lack of
flux through the endocytic pathways.
This malfunctioning of the endosomal network may
account for the unusual and, as far as we know, novel
structures observed in a few of the electron microscopy
sections of the TbnSMase cKO cells (42h–tet) (Fig. 6I and
J and Fig. S8F and G) consisting of concentric ‘onion-like’
vesicular membranes.
Another soluble protein that is found in the
endocytic pathway, protein disulphide isomerise 2 (PDI-2)
(Rubotham et al., 2006), was similarly examined for any
aberrant processing. As a 55 kDa polypeptide, PDI-2 is
subsequently heavily glycosylated into an 80 kDa glyco-
protein in the Golgi, and ultimately colocalizes with p67 in
the terminal endosomes. Western blot analysis of wild-
type and TbnSMase cKO (42h–tet) cells with a-PDI-2 (a
gift from Derek Nolan) revealed equal amounts of the
~80 kDa glycoprotein species (Fig. S11), indicating no
drastic defect in processing.
Does the loss of nSMase affect VSG trafficking?
To investigate the effect, if any, on exocytosis of newly
synthesized VSG reaching the flagellar pocket, cells were
labelled with [35S]-methionine for 1 h, after which total
protein and soluble VSG (sVSG) preparations (obtained
by GPI-PLC cleavage of cell surface VSG only upon mild
hypotonic lysis) were separated by SDS-PAGE and [35S]-
labelled proteins detected by autoradiography. Note:
equal cell equivalents were loaded on the gel, but due to
the ‘Big-Eye’ 2K2N pre-cytokinesis phenotype, the actual
amount of total protein is 1.4 times higher in the TbnS-
Mase cKO (42h–tet) as determined by Bradford and
shown in Fig. 8C (lanes 1 and 2). The total amount of
[35S]-methionine incorporation into protein (excluding
VSG) between the cell lines is similar (Fig. 8C, lanes 1
and 2). Thus at this 42 h time point, TbnSMase cKO cells
were essentially viable based on their ability to synthesize
protein at a level comparable to wild-type cells.
However, it is clear that the proportion of newly synthe-
sized ([35S]-methionine labelled) VSG exported to the cell
surface, i.e. the radiolabelled sVSG, is drastically reduced
in the TbnSMase cKO (42h–tet) cells, when compared
Fig. 7. Investigation of the endosomal
network. Wild-type cells (A) and TbnSMase
cKO cells grown in the absence of
tetracycline for 42 h (B–D) probed with
anti-trypanopain. Images are of TRITC,
DAPI-fluorescence and DIC.
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Fig. 8. Phenotypic analysis of protein trafficking in the nSMase conditional knockout.
A. Wild-type and TbnSMase cKO cells grown in the absence of tetracycline for 42 h were pulse labelled with [35S]-methionine for 1 h (lanes 1
and 3 respectively) and chased for further 2 h (lanes 2 and 4 respectively) prior to IP with anti-P67 as described in Experimental procedures.
The resulting IP [35S]-proteins was separated on a 10% SDS-PAGE gel, prior to Coomassie blue staining (Fig. S6) and fluorography. The
various maturation sizes of P67 are highlighted.
B. Anti-trypanopain Western blot analysis of wild-type (lane 1) and TbnSMase cKO cells grown in the absence of tetracycline for 42 h (lane 2)
shows incomplete endosomal processing. The maturation sizes of trypanopain are highlighted.
C. Wild-type (lanes 1 and 3) and TbnSMase cKO cells grown in the absence of tetracycline for 42 h (lanes 2 and 4) were labelled with
[35S]methionine for 1 h. Total [35S]-protein (lanes 1 and 2) or [35S]-sVSG (soluble VSG-obtained from the cell surface of the parasite) (lanes 3
and 4) prepared as described in Experimental procedures were separated on a 10% SDS-PAGE gel, and visualized either by Coomassie blue
or fluorography. The black arrow (lane 1) refers to a protein that is no longer being synthesized in the TbnSMase cKO (-tet) cells (lane 2).
D. Wild-type (lanes 1 and 2) and TbnSMase cKO cells grown in the absence of tetracycline for 42 h (lanes 3 and 4) were labelled with
[3H]myristate for 1 h in the absence (lanes 1 and 4) or presence of cycloheximide (60 mg ml-1) (lanes 2 and 3) as described in Experimental
procedures. Densitometry (ImageJ) of the [3H]myristate-mfVSG (membrane form VSG, processes an intact GPI-anchor) signals is normalized
to 100% for the wild-type cells in the absence of cycloheximide. Lower panel shows the VSG portion of the gel stained with Coomassie blue
as loading control.
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with the Coomassie stained sVSG (Fig. 8C, lanes 3 and
4) and the a-VSG221 Western blot analysis (Fig. S9B),
thus one can conclude that the rate of newly synthesized
VSG getting to the cell surface has been drastically
reduced in the TbnSMase cKO (42h–tet) cells. The
protein bands other than sVSG have very similar amounts
of [35S]-methionine incorporation, showing that protein
synthesis was still taking place. The exception to this is a
~80 kDa protein (Fig. 8C, lane 1, black arrow), the corre-
sponding protein band that was identified by mass finger-
printing as possibly either HSP-70 or PDI-2, interestingly,
both of which are involved in protein folding.
To investigate this defect in VSG synthesis, and its
subsequent exocytosis, both wild-type and TbnSMase
cKO (42h–tet) cell lines were labelled with [3H]-myristate.
As expected in wild-type cells the mature membrane form
GPI-anchored VSG (mfVSG) was [3H]-myristate labelled
(Fig. 8D, lane 1). The corresponding [3H]-myristate
labelled mfVSG in the TbnSMase cKO (42h–tet) cells
however was significantly reduced (~12%) (Fig. 8D, lane
4). This significant reduction prompted an assessment of
the myristate exchange of the GPI anchor of pre-existing
VSG, which takes place during endocytosis. As previously
shown, in the presence of cycloheximide (to inhibit protein
synthesis), the myristate exchange in wild-type cells
shows a residual ~30% (Fig. 8D, lane 2) [3H]-myristate
incorporation (Buxbaum et al., 1996). However, in the
TbnSMase cKO (42h–tet) cells the incorporation is
reduced to a mere ~3% compared with wild-type level.
Despite this significantly reduced amount of myristate
exchanging happening in TbnSMase cKO (42h–tet) cells,
it is approximately the same ratio of myristate exchange to
total myristylated mfVSG observed in wild-type cells, i.e.
3–12% and 30–100% respectively. This indicates that
despite the rate of endocytoses and exocytoses of mfVSG
being significantly reduced their ratio (relationship) is
maintained.
Discussion
The essentiality of the TbnSMase clearly shows that the
de novo synthesis of ceramide cannot compensate for the
loss of ceramide formation via SM catabolism in the ER.
The nSMase cKO trypanosomes grown under permis-
sive conditions also shows a significant increase in intra-
celluar SM levels, either in the ER and/or the mitochondria
where a SM synthase is present. In conjunction with the
excess SM is a significant decrease in PC, and a corre-
sponding increase in intracelluar DAG. The observed
increase in DAG species of the same diacyl chain length
as the depleted PC species (C38:5 and C40:5) implies
that the de novo synthesis of PC via the Kennedy pathway
has slowed, whereas the synthesis of DAG has not,
resulting in excess DAG. Alternatively, or more likely con-
currently, the rate of SM synthesis continues unabated
resulting in increased SM levels and the by-product DAG,
which is not being utilized or catabolized.
The depletion of the PC in the mitochondrion comes
about because the cells become starved of choline
and/or choline–phosphate as the local pool of choline is
tied up as SM. The absence of the nSMase in the ER
means that no choline–phosphate is liberated, which
could be utilized to synthesize PC via the Kennedy
pathway. As the parasite is auxotrophic for choline, it
must source choline containing phospholipids from the
host environment, probably primarily as components
of low-density-lipoprotein (LDL). However, when the
nSMase cKO is grown under permissive conditions, it
has a greatly reduced endocytic flux, ultimately prevent-
ing the catabolism of both pre-exisiting endosomal SM
or PC, and if any, freshly endocytosed extracellular SM
or PC.
A consequence of this shift in choline usage is that the
mitochondrial associated SM synthase ultimately runs out
of its normal substrate, PC, and starts to utilize PI instead,
thus giving rise to this unusual IPC formation in blood-
stream form T. brucei. This pool of PI in the ER is derived
from the de novo synthesized inositol (Martin and Smith,
2006b). This implies that a mitochondrial SM synthase
can utilize both PC and PI as substrates for the synthesis
of SM and IPC respectively. However, in the bloodstream
form of the parasite it prefers to utilize PC, and only uses
PI if no PC is available. This is in contrast to procyclic cells
where substantial amounts of IPC have been observed in
purified mitochondria, despite there being ample PC avail-
able (Güler et al., 2008).
An alternative possibility for the observed IPC formation
is that the de novo synthesized ceramide is translocated
to the Golgi where the resident SM synthase (SLS4),
known to be capable of utilizing both PC and PI (Mina
et al., 2009), now starved of PC utilizes a different pool of
PI, which is synthesized in the Golgi from the extracellular
inositol (Martin and Smith, 2006a). The transition of PC to
PI utilization as substrates by mitochondrial SM syn-
thase(s) also occurs during bloodstream long-slender to
stumpy form differentiation, where IPC formation is clearly
observed along with dramatic upregulation of a mitochon-
drial associated SM synthase (SLS1) (Kabani et al.,
2009). These observations imply that both stumpy and
procyclic form parasites have a significantly decreased
rate of ceramide formation in the ER, as there is little, if
any, SM for the nSMase to catabolize, and thus the flux of
post-Golgi sorting of protein destined for the recycling
endosomes and flagellar pocket, which is dependent
upon ceramide from the ER, would be severely reduced.
Collectively, these results allow us to propose an
updated model of the endocytic and exocytic pathways in
bloodstream form T. brucei (Fig. 9A), along with an expla-
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Fig. 9. Schematic of the pathways involved in endocytosis and exocytosis in bloodstream form T. brucei: wild-type (A) and the nSMase cKO
grown under permissive conditions (B). The difference in the width of the arrows in (A) and (B) depicts the relative changes in the flux for the
same vesicular trafficking pathway in the wild-type cells compared with the nSMase cKO grown under permissive conditions. Dashed arrows
indicate putative pathways. The enlarged flagellar pocket and late endosomes are representative of the ‘Big-Eye’ phenotype observed in the
nSMase cKO grown under permissive conditions (B). Annotated cellular structures: EE, early endosomes; ER, endoplasmic reticulum; FP,
flagellar pocket; G, Golgi; L, lysosome; LE, late endosomes; M, mitochondria; MAM, mitochondrion associated membrane; PM, plasma
membrane; RE, recycling endosomes; FL, flagellum. The various types of vesicles are numbered as follows: 1. Endocytic clathrin-coated
vesicles from flagellar pocket to early endosomes, carrying a mixture of endocytosed nutrients, including LDL particles and transferrin bound
to GPI-anchored transferrin receptor, and recycling pre-existing cell surface GPI-anchored VSG, to be checked and undergoing myristate
exchange. 2. Clathrin-coated vesicles from early endosomes to recycling endosomes carrying recycling pre-existing cell surface GPI-anchored
VSG. 3. Clathrin-coated vesicles from early endosomes to late endosomes, carrying a mixture of endocytosed nutrients, including LDL
particles and transferrin bound to GPI-anchored transferrin receptor. 4. Clathrin-coated vesicles from late endosomes to recycling endosomes,
carrying the recycled GPI-anchored transferrin receptor, now free of transferrin, and newly synthesized membrane-bound protein destined for
the flagellar pocket, not newly synthesized GPI-anchored proteins, i.e. VSG. 5. Non-clathrin-coated, sphingomylein-enriched recycling
endosomes destined for the flagellar pocket, which contains recycling GPI-anchored transferrin receptor, recycling VSG and newly synthesized
VSG. 6. Non-clathrin-coated, SM-enriched vesicles from the trans-Golgi cisterna to the recycling endosomes, containing newly synthesized
VSG and possibly other GPI-anchored proteins, ultimately destined for the flagellar pocket and the cell surface. 7. Clathrin-coated vesicles
from the Golgi to late endosomes, containing newly synthesized proteins which will be targeted to go either to the lysosome, i.e. p67 and
trypanopain, or to go via the recycling endosomes to the flagellar pocket, i.e. cell surface proteins other than VSG. 8. Clathrin-coated vesicles
from the late endosomes to the lysosome, containing a mixture of newly synthesized lysosomal proteins, i.e. p67 and trypanopain, and
endocytosed nutrients, i.e. LDL particles and transferrin. 9. CopII vesicles from the ER to the Golgi, carrying all newly synthesized proteins
destined for the endocytic pathway. 10. Putative non-CopII vesicles going to and from the ER and the Golgi, possibly carrying lipids, e.g.
ceramide and PC. 11. Putative SM-enriched vesicle trafficking of VSG directly from the Golgi to the flagellar pocket.
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nation of the effect on these pathways caused by
the nSMase cKO grown under permissive conditions
(Fig. 9B).
Let us discuss the model in the bloodstream form of
the parasite. PC exclusively de novo synthesized via the
Kennedy pathway (Gibellini et al., 2009) and ceramide
are utilized by a mitochondrial resident SM synthase to
form SM. This SM is then translocated to the ER, via the
mitochondria-associated membrane fraction (Bionda
et al., 2004; Achleitner et al., 1999), where the SM
encounters the nSMase, forming ceramide and choline–
phosphate (Vacaru et al., 2009). This ER pool of cera-
mide now travels with more PC from the ER to the Golgi
(Fig. 9, route 9) (Testerink et al., 2009), where in the
trans-Golgi cisterna, a different SM synthase, SLS4
(Tb09211.1000) (Sutterwala et al., 2008), utilizes these
lipid precursors to reform SM, which is subsequently
used for post-Golgi processing of GPI-anchored pro-
teins, i.e VSG. This is similar to the situation in yeast,
where IPC, formed in the Golgi from ceramide de novo
synthesies in the ER and PI, influences GPI-anchored
protein trafficking (Watanabe et al., 2002). This explains
why inhibition of the ceramide de novo pathway by
myrocin, although lethal did not affect transport of GPI-
anchored VSG (Sutterwala et al., 2007).
In the case of the nSMase cKO grown under permissive
conditions, decreasing levels of nSMase activity directly
cause a lack of ceramide and ultimately a lack of PC
(discussed eariler) in the ER, which subsequently reduces
the amount of ceramide travelling to the Golgi (Fig. 9,
route 9). The subsequent lack of SM synthesis in the Golgi
decreases the rate (flux) at which SM-enriched vesicles
containing newly synthesized VSG can be translocated to
the recycling endosomes (Fig. 9, route 6), and beyond to
the flagellar pocket (Fig. 9, route 5). This subsequently
decreases the flux exiting the late endosomes (Fig. 9,
route 4), causing them to enlarge, and reduces the
endocytic rate of pre-exisitng cell surface VSG (Fig. 9,
route 1), from the early endosomes to the recycling endo-
somes (Fig. 9, route 2).
As in other organisms a general question arises, why
SM is not translocated from the ER to the Golgi? The
possible answer may be that transportation of SM from
the ER to Golgi is either detrimental for the cis-Golgi
cisterna and/or the enzymes therein, i.e. glycosidases
and glycosyltransferases. Alternatively, SM is not suitable
for Cop II vesicle formation (Fig. 9, route 9), which is used
for protein trafficking from ER to Golgi (Hughes and
Stephens, 2008). Another previously proposed possibility
is that lipids such as ceramide and PC are transported to
the Golgi via CopII independent vesicles (Funato and
Reizman, 2001) (Fig. 9, route 10), but again why SM
cannot be translocated using these vesicles is unknown.
Interestingly, T. brucei has recently been shown to use a
subset of Cop II vesicles for selectively transporting GPI-
anchored cargo, e.g. VSG, from the ER to Golgi (Sevova
and Bangs, 2009), these vesicles may also contain the
ceramide and PC for SM synthesis.
The model suggests that post-Golgi sorting of proteins
takes place at the trans-Golgi network either by clathrin-
coated vesicles to the late endosome (Fig. 9, route 7), or
SM-enriched vesicles to the recycling endosomes (Fig. 9,
route 6).
Proteins such as p67 and trypanopain targeted to be
translocated to the lysosome (Fig. 9, route 8) are unaf-
fected by the lack of SM formation in the Golgi in the
nSMase cKO cells grown under permissive conditions.
Note, processing and sorting in the enlarged late endo-
some of some proteins are affected, i.e. trypanopain, thus
it is likely that p67 processing by trypanopain, normally
lysosomal, now partially happens in the enlarged late
endosomes.
In the late endosomes lysomal targeted proteins are
joined by endocytosed nutrients, i.e. transferrin and LDL,
that have previously been sorted from the recycling VSG
in the early endosomes (reviewed in Overath and Eng-
stler, 2004) (Fig. 9, route 3), are translocated to the lyso-
some (Fig. 9, route 8).
Other cell surface proteins, i.e. invariant surface glyco-
protein 65 and the recycling transferrin receptor, are
sorted to the recycling endosomes (Fig. 9, route 4) to join
the recycling VSG and the newly synthesized VSG on
route to the flagellar pocket (Engstler et al., 2004).
The alternative post-Golgi sorting pathway utilizes
SM-enriched vesicles to carry newly synthesized VSG,
either via the recycling endosomal network (Fig. 9, route
6) or as has been putatively suggested, directly to the
flagellar pocket (Fig. 9, route 11).
Here in the recycling endosomes is the most likely
place that myristate exchange of pre-existing and newly
synthesized GPI-anchored VSG and potentially other
GPI-anchored proteins, i.e. transferrin receptor takes
place (Buxbaum et al., 1996).
The high flux of SM-enriched recycling endosomes
delivers cargo to the flagellar pocket (Fig. 9, route 5),
allowing the SM to be recycled via endocytosis (Fig. 9,
route 1), via the early and late endosomes to the lyso-
some (Fig. 9, routes 3 and 8), where it will be catabolized
by the putative acidic SMase (Tb 927.4.1120), whose
activity has been shown to work on SM and PC containing
LDL (Coppens et al., 1995).
Based upon this model and our results, the flux
through the endosomal pathway is highly dependent
upon the high rates of flux through both avenues of
post-Golgi sorting, i.e. the late endosome and the recy-
cling endosomes. To extrapolate this model further, if
there is a reduction in the flux from the post-Golgi
sorting to the recycling endosomes, and ultimately to the
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flagellar pocket (exocytosis) (Fig. 9B, routes 6 and 5), as
in the nSMase cKO or the VSG RNAi (Sheader et al.,
2005; Smith et al., 2009), the flux to and from the late
endosome (Fig. 9B, routes 3 and 4) is also affected; in
turn causing a decrease in the rate of protein trafficking
through the exocytic pathway and ultimately the
endocytic pathway. This lack of protein trafficking to the
recycling endosomes causes an enlargement of the late
endosome. Thus, the new material entering the flagellar
pocket cannot be processed leading to an enlargement
of the flagellar pocket, now characteristically known as a
‘Big-Eye’ phenotype.
So, the high endocytic and exocytic rates in blood-
stream form T. brucei are dependent upon high flux of
SM-enriched vesicles from the Golgi to the recycling
endosomes and beyond to the flagellar pocket/cell
surface. This explains the difference in the significantly
higher endocytic and exocytic fluxes in the mammalian
bloodstream form of the parasite compared with that of
the procyclic insect form of the parasites.
In summary, the T. brucei nSMase has been recombi-
natly expressed and shown to be catalytically active. A
high-throughput assay has been developed allowing future
high-throughput screening. Creation of a conditional
knockout in the bloodstream of the parasite allowed
genetic validation as a drug target, and the phenotype of
which has given new insight into the highly active endocytic
and exocytic pathways in bloodstream T. brucei.
This work clearly demonstrates that a decrease in the
rate of deposition of newly synthesized VSG on the cell
surface causes a corresponding decrease in the recycling
of VSG, allowing the trypanosome to maintain an
optimum cell density of its crucial VSG protective coat.
Thus, a new possible strategy in the fight against African
trypanosomasis is to find drugs that selectively interfere
with the post-Golgi transport of VSG. To this end we are
currently investigating nSMase inhibitors as potential anti-
trypanosomal drugs.
Experimental procedures
Cloning of the T. brucei nSMase gene and ligation into
pLew vectors
A putative nSMase gene was identified in the T. brucei
genome database (Tb927.5.3710 – Sanger Institute).
The ORF was amplified from T. brucei strain 427
genomic DNA using the forward and reverse primers
5′-GAGGAGAAGCTTATGGCTGCAGAGATAACTG-3′ and
5′-TGCTTAATTAATTTACAACCATTACCTTTATGC-3′ con-
taining HindIII and PacI restriction sites respectively
(underlined). A band of the expected size of c. 1.7 kb was
amplified using KOD Hot Start DNA polymerase (Merck Bio-
sciences Ltd), purified using a QIAquick PCR purification kit
(Qiagen) and cloned into pCR-Blunt II TOPO (Invitrogen).
The TbnSMase ORF was excised using HindIII and PacI, and
subsequently ligated into the tetracycline-inducible expres-
sion vectors pLew82 and pLew100 (Wirtz et al., 1999) via the
HindIII and PacI restriction sites. Plasmid DNA was prepared
by linearization with NotI subsequently precipitated with
sodium acetate/ethanol and redissolved in sterile water to a
final concentration of 2 mg ml-1, ready for transfection.
Construction of T. brucei gene replacement cassettes
The 5′ and 3′ untranslated regions (UTRs) immediately adja-
cent to the nSMase ORF were amplified from T. brucei
genomic DNA using KOD Hot Start DNA polymerase. The
primers 5′-ATAAGTAAGCGGCCGCGCGTTTGGGCTGTT
CTCGTT-3′ and 5′-CGTTTAAACTTACGGACCGTCAAGCTT
TTTTGAGTTTAATTCAGTGGG-3′ were used for the 5′ UTR,
amplifying the expected 468 bp product, and primers
5′-tgacggtccgtaagtttaaacggATCCAGAGGATTGCTTCATCAT
CATG-3′ and 5′-ATAAGTAAGCGGCCGCTCCCCTCTGCG
TAGTGGTAAAATA-3′ resulted in the correct 298 bp product
of the 3′ UTR. These amplified products were used in a
subsequent knitting PCR, resulting in a 744 bp product in
which the 5′ UTR was joined to the 3′ UTR via a short
complementary BamHI-HindIII linker region contained within
the described primers (italics). This PCR product was ligated
into pGEM-5Zf(+) (Promega) via the NotI sites (underlined in
the original primers) followed by the insertion of the hygro-
mycin (HYG) or puromycin (PAC) resistance genes between
the cut BamHI and HindIII restriction sites. Plasmid DNA was
prepared using a QIAprep Miniprep Plasmid Kit (Qiagen),
and digested with NotI upon precipitation with sodium
acetate/ethanol it was redissolved in sterile water to a final
concentration of 2 mg ml-1, ready for transfection.
Cultivation and genetic modification of T. brucei
Bloodstream form T. brucei strain 427, which had been pre-
viously modified to express both T7 polymerase and the
tetracycline repressor protein (Wirtz et al., 1999), is referred
to here as wild-type cells for convenience. Cells were grown
in HMI-9 media supplemented with G418 (2.5 mg ml-1), at
37°C with 5% CO2 as described elsewhere (Wirtz et al., 1999;
Chang et al., 2002; Roper et al., 2002). Transformation con-
ditions and subsequent drug selection were also described
elsewhere (Burkard et al., 2007). Addition of tetracycline to
the media when required was at a final concentration of
1 mg ml-1. For tetracycline-free experiments, Tet system-
approved fetal calf serum (Clontech) was used and cells were
washed three times in tetracycline-free HMI-9 and resus-
pended in the same tetracycline-free media at 5 ¥ 104
cells ml-1. Cells were counted each day and were passaged
only when the density was greater than 7 ¥ 105 cells ml-1
(normally every second day).
Expression of T. brucei nSMase in E. coli
The nSMase ORF was amplified from the TbnSMase-TOPO
plasmid with KOD Hot Start DNA polymerase using the
primers 5′-GAGGGATCCATGGCTGCAGAGATAACTGTTC-
3′ and 5′-TGCCCCGGGTCATTTACAACCATTACCTTTATG-
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3′, resulting in a single band of c. 1.7 kb. The amplified product
was purified using a QIAquick PCR purification kit (Qiagen)
prior to blunt-end cloning into pCR-Blunt II-TOPO (Invitrogen)
for sequencing. The reading frame was digested out and
ligated into the pGEX-6P-1 vector (GE Healthcare) using the
BamHI and SmaI sites (underlined) and the sequence con-
firmed. This construct was transformed into E. coli C43 (DE3)
competent cells for expression. A single colony was used to
inoculate 5 ml of Luria–Bertani media containing 100 mg ml-1
ampicillin and 0.5% glucose (w/v) and grown at 37°C over-
night. The 5 ml was added to 500 ml of overnight express
instant TB medium (Merck Biosciences Ltd) containing
100 mg ml-1 ampicillin and grown at 37°C for 4 h, after which
the culture was incubated for a further 20 h at 25°C. Cells were
harvested by centrifugation (1800 g, 15 min) and resus-
pended in lysis buffer [50 mM Tris pH 8.0, 300 mM NaCl, 10%
Glycerol (v/v), 5 mM MgCl2, 1 mM DTT] and incubated at 37°C
with 0.2 mg ml-1 lysozyme (Sigma) and 250 U benzonase
nuclease (Merck) for 30 min. Cells were disrupted by sonica-
tion (4 ¥ 60 s) on ice and the cell debris, whole cells and
ghosts were cleared by slow-speed centrifugation (14 500 g,
10 min, 4°C). Expression and identification of the GST–
TbnSMase was confirmed by Western blotting using anti-GST
antibodies (Covance) and ECL Western detection reagents
(Amersham). Subsequently, E. coli membranes containing
GST–TbnSMase were collected by high-speed centrifugation
(100 000 g, 1 h), washed in PBS and suspended in 100 mM
Tris (pH 7.4), 10 mM MgCl2 and 20% glycerol and stored as
aliquots at -80°C. Protein was extracted from the GST–
TbnSMase membranes by solubilizing in 1% Triton X-100 prior
to determining the total protein content using the BCA protein
assay kit (Thermo Scientific).
nSMase enzyme assays
Sphingomyelinase activity was confirmed by the use of radio-
active [3H]-SM, washed membranes (containing 127 mg of
total protein as determined by using a BCA assay kit (Thermo
Scientific) encoding GST–TbnSMase incubated in 100 mM
Bis-Tris propane (pH 7.5), differing concentrations of MgCl2
(as stated in the individual figures), 0.5% glycerol with 25 nCi
[choline-methyl-3H]SM (50 Ci mmol-1, ARC) and 50 pmol cold
SM presented as mixed micelles with 0.1% Triton-X 100.
Reactions were incubated at 37°C for 120 min. Hydrolysis of
PC was assayed in an identical manner with 30 nCi
[3H-choline-methyl]PC (60 Ci mmol-1, ARC) and 50 pmol cold
PC presented as mixed micelles with 0.1% Triton-X 100. For
analysis of the optimum pH for activity, the pH of the reaction
buffer was altered accordingly. Reactions (50 ml) were
stopped by the addition of 800 ml chloroform:methanol (2:1
v/v) followed by 250 ml H2O. After phase separation, aqueous
and organic phases were dried down and resuspended in
50% propan-1-ol or 100% butan-1-ol and examined by TLC
using solvent systems of methanol:0.6% NaCl:25% NH3
(100:100:10) or chloroform:methanol:water (10:10:3 v/v)
respectively.
Neutral sphingomyelinase activity was further character-
ized using the Amplex Red sphingomyelinase assay kit (Invit-
rogen Ltd, He et al., 2002). Briefly, washed membranes
(containing 254 mg of total protein) encoding GST–
TbnSMase were incubated in 100 mM Tris-HCl (pH 7.4),
10 mM MgCl2, 0.5% glycerol with varying amounts of SM
(presented as mixed micelles with 0.1% Triton-X 100). Pro-
duction of choline phosphate from SM was detected by inclu-
sion of the standard Amplex red assay components in a final
assay volume of 200 ml. Reaction mixtures were incubated at
30°C for 1 h and the fluorescence product generated mea-
sured kinetically (Excitation 56 0nm, Emission 587 nm). T.
brucei bloodstream form washed membranes prepared as
above and containing an estimated 35 mg of total protein
were assayed for nSMase activity in an identical manner with
100 mM SM (presented as mixed micelles with 0.1% Triton-X
100). Inhibitor studies with the trypanosomal membranes
were conducted by pre-incubation of up to 500 mM of inhibitor
for 15 min, prior to the addition of 100 mM SM, and Amplex
red for 30 min 37°C.
Inhibitor studies with GST–TbnSMase were conducted by
pre-incubation of 50 mM inhibitors for 30 min prior to the addi-
tion of 100 mM SM and Amplex red for 30 min 37°C.
Southern blots
The nSMase ORF was PCR-amplified using the same ORF
primers as for the pLew vectors and gel purified and labelled
with DIG- (Roche). Genomic T. brucei DNA (3 mg) was
digested with various restriction enzymes. Digestion products
were separated on a 0.8% agarose gel and transferred to
Hybond-N+ membrane (Amersham), and hybridized over-
night in ULTRA-HYB (Ambion) at 42°C with the dig-labelled
nSMase ORF probe. Stringency washes were carried out at
42°C, and consisted of two washes at low stringency for
15 min each [2¥ SSC (300 mM NaCl, 30 mM sodium citrate),
0.1% SDS] and two washes at high stringency again for
15 min each [0.2¥ SSC (30 mM NaCl, 3 mM sodium citrate),
0.1% SDS]. Bound probe was detected by anti-Dig antibody
following manufacturers instructions.
RNA isolation and cDNA synthesis
Total RNA was isolated from bloodstream form T. brucei using
the RNeasy mini kit (Qiagen). TbnSMase-specific cDNA
was generated and amplified using the specific forward
5′-GAGGAGCATATGGCTGCAGAGATAACTGTTC-3′ and
reverse 5′-TGCGGATCCTCAAGCTTCACATAGAGACGCC
TC-3′ primers using the SuperScript III One step RT-PCR kit
with Platinum Taq (Invitrogen).As a negative control to exclude
DNA contamination of the RNA sample, reverse transcriptase
was omitted from the reaction and replaced with GoTaq poly-
merase (Promega). Inositol-3-phosphate synthase (TbINO1)
cDNA was also amplified using the forward and reverse
primers 5′-AGCGGCAAGCTTCTATGCCAGCCGTCCGTA
CGAAAA-3′ and 5′-CGACCTCGAGGTCAACTTCCCACG
CCGCGAAGGAAAGGCAG-3′ to confirm equal RNA loading.
The PCR products were then run on a 1% agarose gel.
Subcellular localization studies
Tetracycline-induced mid-log T. brucei nSMase-HA Ti blood-
stream form cells were harvested by centrifugation (800 g,
10 min) and used for either immunofluorescence or differential
centrifugation as previously described (Martin and Smith,
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2006b). The blocked cells were incubated with either rat a-HA
(Roche) or rabbit a-trypanopain antibody (James Bangs, Uni-
versity of Wisconsin-Madison) followed by their respective
secondary; FITC conjugated rabbit anti-rat (DakoCytomation)
and TRITC conjugated Goat anti-rabbit immunoglobulins
(Sigma). 4,6-diamidino-2-phenylindole (DAPI) staining was
used to reveal the localization of the nuclear and kDNA.
Differential centrifugation and Western analysis for
HA-tagged protein were detected using the primary rat a-HA
(Roche), and secondary HRP-conjugated rabbit a-rat
(Jackson) antibodies and ECL Western detection reagents
(Amersham) were used as described previously (Martin and
Smith, 2006a).
In vivo T. brucei metabolic labelling
For each metabolic labelling, mid-log trypanosomes were
centrifuged (800 g, 10 min), washed in minimal essential
media before being resuspended in the specific supplement
free media at a final concentration of 1 ¥ 107 cells ml-1. Cells
were labelled for 2 h at 37°C with [9,10-3H] myristic acid
(47 Ci mmol-1, Perkin Elmer) complexed to defatted-BSA
(1 mol mol-1) in a shaking water bath. Cells were collected by
centrifugation (800 g, 10 min), washed twice in trypanosome
dilution buffer (TDB) buffer and processed for either lipid or
protein analysis. Lipids were extracted using chloroform:
methanol: water (10:10:3 v/v) for 1 h, the supernatant
removed and the pellet re-extracted with chloroform:methanol
(2:1 v/v) for 1 h. The pooled supernatants were dried, prior to
desalting using butanol/water partioning. Lipids were sepa-
rated on silica 60 high-performance thin layer chromatography
(HPTLC) plates, with chloroform : methanol : ammonia
(13 M) : ammonium acetate (1 M) : water, (180 : 140 : 9 : 9 :
23 v/v) as the solvent. Radiolabelled lipids were detected by
fluorography at -70°C, after spraying with En3hance and using
Kodak XAR-5 film with an intensifying screen. Protein samples
(cell pellets) were quenched in 2¥ SDS-PAGE sample buffer
and heated at 95°C for 5 min. Proteins were separated on a
10% SDS-PAGE gel and visualized by Coomassie blue stain-
ing. To detect [3H]-labelled proteins the destained gel was
soaked in En3hance (NEN) for 30 min, washed with water
three times, soaked in 10% glycerol and dried and exposed to
XAR-5 film at -80°C.
When labelling with [35S]-methionine, mid-log cells were
collected by centrifugation, washed in methionine free minimal
essential media and resuspended in the same media at a final
concentration of 1 ¥ 107cells ml-1. Cells were labelled for
1 h with 20 mCi ml-1 [35S]-methionine (MP Biomedicals,
1175 Ci mmol-1) at 37°C. Small-scale sVSG purification was
as performed as described previously (Jones et al., 2005).
For the immunoprecipitation (IP) of [35S]-p67 from T. brucei,
the protocol of Alexander et al. (2002) was followed with some
modifications. Briefly, 5 ¥ 106 [35S]-methionine pulse-labelled
(1 h) trypanosomes were harvested at each time point (0 and
2 h), washed once in PBS and solubilized in 500 ml of lysis
buffer [TEN buffer, 1% Nonidet P-40, 0.5% deoxycholate,
0.1% SDS (TEN buffer = 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA)] containing a protease inhibitor cocktail.
The extracts were precleared by centrifugation (14 000 rpm,
5 min) before detergents (1% Nonidet P-40, 0.5% deoxycho-
late, 0.1% SDS) were added to the culture supernatants to the
same concentration as the lysis buffer (1% Nonidet P-40, 0.5%
deoxycholate, 0.1% SDS). Monoclonal anti-p67 (mAb280)
antibody (a gift of James Bangs, University of Wisconsin-
Madison), which recognizes an uncharacterized peptide
epitope in the p67 lumenal domain, was preadsorbed to
Protein G-Sepharose 4B Fast Flow resin (Sigma) prior to
incubation with the solubilized protein for 1 h at 4°C. After
incubation, resin beads were washed four times with lysis
buffer and once with TEN buffer. Following centrifugation the
resin from each time point was suspended in an equal volume
of 2¥SDS-PAGE sample buffer prior to denaturing at 100°C for
10 min, to release the complexes from the protein G
sepharose. Proteins were separated on a 10% SDS-PAGE gel
and visualized by Coomassie blue staining. To detect [35S]-
labelled proteins the destained gel was soaked in En3hance
(NEN) and detected by autoradiography as described before.
FACS analysis
Cells were stained with propidium iodide as described previ-
ously (Hammarton et al., 2003). Briefly, cells were fixed in
70% methanol, 30% PBS (1¥106 cells ml-1) and incubated at
4°C overnight. Cells were washed in cold PBS, resuspended
in 1 ml of PBS containing 10 mg ml-1 propidium iodide and
10 mg ml-1 RNase A, and incubated at 37°C for 45 min. FACS
was performed using a Becton Dickinson FACScan using
detector FL2-A.
Duplicate data sets were collected and analysed using
WinMDI software (http://facs.scripps.edu) utilizing 10 000
events which were collected for each sample. Cells in a
particular stage of the cell cycle (G0/G1, S, G2/M or >G2/M)
are indicated as a percentage of the total. The gates used for
quantification of the different stages are as in Sheader et al.
(2005).
Lipidomic analysis
Phospholipid analysis was performed on bloodstream wild-
type and TbnSMase cKO trypanosomes (1 ¥ 108) in the pres-
ence or absence of tetracycline for 42 h. Cells were harvested
and washed in TDB and extracted according to the method of
Bligh–Dyer (Bligh and Dyer, 1959), were dried under N2, and
were stored at 4°C until analysed by electrospray mass spec-
trometry (ES-MS and ES-MS/MS) as described previously
(Richmond and Smith, 2007; Gibellini et al., 2009; Richmond
et al., 2010).
Western blotting
Specific T. brucei proteins were detected by Western blot
analysis, using either rabbit a-VSG221 or rabbit
a-trypanopain (gifts from James Bangs, University of
Wisconsin-Madison) or rabbit a-PDI-2 (a gift from Derek
Nolan, Trinity College Dublin) antibodies with secondary rat
a-rabbit HRP-conjugated antibody (Jackson ImmunoRe-
search Ltd). ECL detection reagents (GE Healthcare) were
utilized to visualize the signal.
FITC-BSA uptake assay
Mid-log trypanosomes were harvested by centrifugation
(800 g, 10 min) and resuspended at 1 ¥ 106 ml-1 in minimal
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essential media. The cells are preincubated for 10 min at
37°C before FITC-BSA is added at a final concentration of
5 mg ml-1. After incubation for 30 min, the cells were har-
vested by centrifugation and washed twice in PBS to remove
unbound FITC-BSA, prior to fixation in 4% paraformaldehyde
and processed for immunofluorescence analysis as
described above.
Electron Microscopy
For transmission electron microscopy cell pellets were fixed
for up to 24 h with Peter’s fixative (1.25% glutataldehyde, 1%
paraformaldehyde in 0.08 M sodium cacodylate pH 7.2 with
0.02% calcium chloride). Samples were rinsed twice in 1%
tannic acid for 10 min post-fixed/stained with 0.5% osmium
tetraoxide (aq) for 1 h. Specimens were then rinsed twice in
distilled water before fixation/staining in 1% uranyl acid fol-
lowed by infiltration/embedding in Spurr resin. Sections were
cut using a Leica Ultracut UCT microtome, mounted on piolo-
form coated copper grids, post-stained with 3% uranyl acid
(aq) and Reynold’s lead citrate and examined using a Tecnai
12 BioTWIN made by FEI, and it was operated at 120 kV.
Images were collected using an SIS Megaview III, as 2 ¥ 2
montages.
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